3:00-3:20 | Fatty liver disease in special populations: HIV, viral hepatitis and inflammatory bowel diseases |
Gaidaa Sebstiana |
3:20-3:30 | Bacteriophage: future of personalized management of infectious diseases |
Heba Abdalla |
3:30-3:45 | STI | UK |
3:45-4:00 | Is vancomycin still the 1st. choice in MRSA bacteremia debates & update |
Hanan Soliman |